Inventor
Olivier Soula
Inventor
Meyzieu, FR
Overview
Patents· 34 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C08BPolysaccharides11%
C07KPeptides7%
A01NPreservation of bodies of humans or animals or plants or parts thereof5%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds4%
C07HSugars2%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
10,792,335Rapid-acting insulin composition comprising a substituted citrate202010,583,175Rapid-acting insulin formulation comprising a substituted anionic compound202010,548,952Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals202010,485,851Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid201910,449,256Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer201910,383,918Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid201910,383,920Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals201910,335,489Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid2019RE046686'Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications'20189,795,678'Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound'20179,775,355'Guanidine derivative compounds'20179,700,599'Rapid-acting insulin formulation comprising a substituted anionic compound'20179,492,467'Rapid-acting insulin formulation comprising an oligosaccharide'20169,493,583'Anionic polysaccharides functionalized by a hydrophobic acid derivative'20169,457,089'Highly concentrated aqueous protein solution with reduced viscosity'20169,233,993'N-phosphonomethylglycine guanidine derivative salts'20169,198,971'Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid'20159,115,218'Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer'20159,089,476'Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5'20159,018,190'Functionalized oligosaccharides'20158,679,540'Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications'20148,669,227'Fast-acting insulin formulation'20148,629,124'Dextran functionalized by hydrophobic amino acids'20148,546,356'Administration form of osteogenic protein complexes'20138,497,253'Administration form of osteogenic protein complexes'20138,426,382'Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative'20138,389,661'Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs'20138,367,640'Complex consisted of a polysaccharide and an HBP'20138,293,255'Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes'20128,241,620'Complex polymere amphiphile-PDGF'20128,084,045'Pharmaceutical formulations for the prolonged release of active principle(s) and their applications'20118,017,156'Long-acting colloidal insulin formulation and its preparation'20116,500,783'Process and compositions promoting biological effectiveness of exogenous chemical substances in plants'20026,133,199'Process and compositions promoting biological effectiveness of exogenous chemical substances in plants'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000Based in Lyons, FR· patent location history
2002Based in Lyon, FR· patent location history
2011–2016Patents assigned to SOULA OLIVIER (15)· patent assignee history
2011–2016Patents assigned to FLAMEL TECH SA (5)· patent assignee history
2011–2020Based in Meyzieu, FR· patent location history
2012–2020Patents assigned to ADOCIA (24)· patent assignee history
2012–2016Patents assigned to SOULA REMI (11)· patent assignee history
2012–2015Patents assigned to SOULA GERARD (8)· patent assignee history
2016–2017Based in Venissieux, FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ADOCIA | 24 | 2012–2020 |
| SOULA OLIVIERself | 15 | 2011–2016 |
| SOULA REMI | 11 | 2012–2016 |
| SOULA GERARD | 8 | 2012–2015 |
| FLAMEL TECH SA | 5 | 2011–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Meyzieu, FR | 30 | 2011–2020 |
| Venissieux, FR | 2 | 2016–2017 |
| Lyon, FR | 1 | 2002 |
| Lyons, FR | 1 | 2000 |